Continuing strategies for inhibiting Alzheimer's γ-secretase

Journal of Molecular Neuroscience

Volumn 19, Issue 1-2, 2002, Pages 83-87

  Wolfe, Michael S ^a   Esler, William P ^a   Das, Chittaranjan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Affinity labeling; Alzheimer's disease; Amyloid; Aspartate; Protease

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; HYDROXYETHYLUREA; PEPTIDOMIMETIC AGENT; PRESENILIN 1; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME PURIFICATION; IC 50; NEUROPATHOLOGY;

EID: 0036675744     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-002-0015-5     Document Type: Article

References (22)

1. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons
2. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
3. A portrait of Alzheimer secretases: New features and familiar faces
4. Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate
5. HIV-protease inhibitors
6. Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere
7. Renin inhibitors
8. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor
9. HIV protease: A novel chemotherapeutic target for AIDS
10. Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: Implications for the viral fusion mechanism
11. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation
12. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
13. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein
14. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation
15. Difluoro ketone peptidomimetics suggest a large S1 pocket for Alzheimer's γ-secretase: Implications for inhibitor design
16. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors
17. Secretase targets for Alzheimer's disease: Identification and therapeutic potential
18. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease
19. (Hydroxyethyl) urea-containing peptidomimetics: New molecular probes for γ-secretase/presenilin
20. The role of presenilins in gamma-secretase activity
21. Peptidomimetic probes and molecular modeling suggest Alzheimer's γ-secretases are intramembrane-cleaving aspartyl proteases
22. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity